Muhi Sirajuddin

Q: What is Muhi Sirajuddin email address?

Email Muhi Sirajuddin at muhi.sirajuddin@tr1x.bio. This email is the most updated Muhi Sirajuddin email found in 2026.

Q: How to contact Muhi Sirajuddin?

To contact Muhi Sirajuddin send an email to muhi.sirajuddin@tr1x.bio. (updated on November 04, 2024)

Senior Director Clinical Operations at Tr1X | San Diego, California, United States

About Muhi Sirajuddin

Muhi Sirajuddin serves as the Senior Director of Clinical Operations at Tr1X, where he plays a pivotal role in advancing the company’s innovative assets from the laboratory to the clinic. With over 14 years of comprehensive experience in the clinical research sector, Muhi has honed his expertise in managing complex projects across various phases of clinical trials, including first-in-human studies and large-scale global Phase III trials. His extensive background encompasses all facets of clinical study management, from protocol development and feasibility assessments to navigating submissions to regulatory bodies such as the U.S. Food and Drug Administration (FDA) and international Ministries of Health.

At Tr1X, Muhi is currently leading key initiatives that focus on program implementation and the strategic oversight of clinical operations. His adeptness in CRO management ensures that partnerships with contract research organizations are optimized for efficiency and compliance, facilitating seamless study execution. Muhi's proficiency in regulatory requirements, including Investigational New Drug (IND) applications and Clinical Trial Applications (CTA), positions him as a critical asset in ensuring that Tr1X meets all necessary guidelines while advancing its clinical programs.

His leadership skills are complemented by a strong foundation in clinical data management, enabling him to drive data integrity and accuracy throughout the study lifecycle. Muhi’s commitment to excellence and his strategic vision are instrumental in propelling Tr1X’s mission forward, ultimately aiming to deliver groundbreaking therapies that address unmet medical needs. Through his collaborative approach and deep industry knowledge, Muhi continues to make significant contributions to the success of Tr1X’s clinical endeavors.

Muhi Sirajuddin Work